Heart Failure, Indications for Lead Removal
Conditions
Keywords
Extraction, Removal, Lead, Heart Failure
Brief summary
The purpose of this study is to characterize the removability of the Attain StarFix® Model 4195 Left Ventricular (LV) Lead (StarFix®). The goal of the trial is to evaluate the lead removal success in patients that are indicated for left ventricular lead removal. This study is required by the Food and Drug Administration (FDA) as a condition of approval for the Attain StarFix® Model 4195 LV Lead.
Interventions
Removal of a LV lead using any tools & techniques.
Sponsors
Study design
Eligibility
Inclusion criteria
* Subjects with a Class I/II indication and/or physician discretion for left ventricular lead removal * Medtronic Model 4195 LV lead implanted for at least 181 days at time of extraction, or other Medtronic LV Lead (non-Model 4195) implanted for at least 181 days at time of extraction, or Medtronic Model 4195 LV lead implanted for 90-180 days * Intention to remove the LV lead prior to the extraction procedure * Subject is 18 years of age or older * Subject (or subject's legally authorized representative) has signed and dated the Patient Consent Form and is willing and able to comply with the protocol
Exclusion criteria
* None
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Removal success of LV leads implanted for more than 180 days | More than 180 days post-implant |
Secondary
| Measure | Time frame |
|---|---|
| Success of lead removal by how long the lead has been implanted | More than 180 days post-implant |
| Adverse Events that are related to the LV lead, the extraction procedure, or the extraction tool. | 0 to 45 days post-lead extraction |
| Removal success of Medtronic Model 4195 LV Leads implanted for 90-180 days | 90 -180 days post-implant |
| Summary of tools & techniques used to remove LV leads. | More than 180 days post-implant |
Countries
Canada, United States